Molecular Classification and Predictive Biomarkers in Endometrial Carcinoma


LIVE WEBINAR: October 31, 2024 | 11:00am-12:00pm ET

Free for members and $29 for nonmembers


This interactive live webinar is part 17 of the Emerging and Evolving Biomarkers Series

Description:

In this session, we will review The Cancer Genome Atlas (TCGA) molecular classification in endometrial carcinoma and how these subtypes are integrated with histologic classification and staging, as well as review the clinical implications. We will describe various approaches and assays for determining the molecular subtype and discuss associated pitfalls and challenges. Lastly we will cover ERBB2 (HER2) predictive biomarker testing in endometrial cancer.

Learning Objectives:
  • Accurately classify endometrial cancers into one of the four TCGA molecular subtypes and compare the clinical features and staging implications.
  • Describe the methods for establishing TCGA molecular classification in endometrial carcinoma.
  • Describe ERBB2 (HER2) predictive biomarker testing in endometrial carcinoma.


Speaker:

Brooke E. Howitt, MD
Stanford Medicine

Moderator:
Pawel Mroz, MD, PhD
University of Minnesota Medical School


Duration: 1 Hour
Level of Instruction: Intermediate
Live webinar: October 31, 2024

How to Register:
  1. Click the "Register Now" Button
  2. Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account.
  3. Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
  4. Registration for this course includes the live webinar link, the webinar recording, PDF of the slides, pre- and post- knowledge check questions, and continuing education credit (CME and CMLE)

Continuing Education Credit Information

CME credit: 1.0
CMLE credit: 1.0 
Last day to claim credit: December 31, 2026

Accreditation Statements
AMA PRA Category 1 Credit(s)
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.